On this page
AHI1
Abelson helper integration site 1
AHI1 is located on the long (q) arm of chromosome 6, at band 6q23.3. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 6 in the library →Available at Jeen Health
Clinical tests that include this
Overview
AHI1 (Abelson helper integration site 1) is located on chromosome 6 and produces a 1,196 amino acid protein involved in ciliary assembly and signalling. Cilia are cellular appendages that act as sensory antennae, detecting chemical and mechanical signals in the environment and coordinating developmental processes. The AHI1 protein localises to structures called transition zones at the base of cilia, where it helps regulate the movement of molecules in and out of these compartments.
Biallelic pathogenic variants in AHI1 underlie a subset of Joubert syndrome cases, a neurodevelopmental ciliopathy. Because AHI1 follows an autosomal recessive inheritance pattern, affected individuals inherit one non-functional copy from each parent, who are typically unaffected carriers. The gene's role in multiple organ systems explains the varied clinical features observed in Joubert syndrome.
What the gene does
The AHI1 protein functions primarily at the ciliary transition zone, a gatekeeper region controlling protein trafficking into and out of the cilium. This localisation is critical for maintaining the distinct protein composition of cilia compared to the rest of the cell. AHI1 interacts with numerous other ciliary proteins to form multiprotein complexes that anchor to the ciliary membrane and coordinate signalling pathways essential for development.
One key interaction partner is HAP1 (huntingtin-associated protein 1), which connects AHI1 to intracellular transport systems. Through its WD repeat domains, AHI1 assembles into larger protein scaffolds that facilitate signal transduction cascades, particularly pathways involving Sonic Hedgehog and Wnt signalling during embryonic development. These pathways direct cell fate decisions, tissue patterning, and organ formation. The protein's SH3 domain mediates additional protein-protein interactions, enabling AHI1 to coordinate multiple cellular processes simultaneously. Disruption of AHI1 function impairs ciliary assembly and compromises the cell's ability to respond appropriately to developmental signals.
Video: Genetics 101
Chromosome location
AHI1 is located on the long arm of chromosome 6 at position 23.3 (6q23.3). This chromosomal region contains multiple genes involved in developmental processes. The AHI1 locus spans a substantial genomic segment and includes regulatory sequences that control when and where the gene is expressed during development and in adult tissues.
Protein structure
The AHI1 protein exhibits a modular architecture with distinct functional regions. Near the amino terminus, a coiled coil domain (amino acids 13-45) facilitates protein-protein interactions and may contribute to oligomerisation. The protein contains an extended interaction region with HAP1 (amino acids 141-434), enabling connection to intracellular trafficking machinery.
The carboxy-terminal half of AHI1 features seven WD repeats (WD 1 through WD 7, spanning amino acids 607-926) that fold into a propeller-shaped structure characteristic of this domain family. WD repeat domains typically serve as platforms for assembling multiprotein complexes. Following the WD repeats, an SH3 domain (amino acids 1051-1111) provides additional protein-binding capacity. Interspersed throughout the sequence are several disordered regions (amino acids 56-186, 215-242, 254-327, and 1115-1196), which often mediate regulatory interactions and allow conformational flexibility. This domain organisation enables AHI1 to function as a scaffolding protein, bringing together diverse signalling components at the ciliary transition zone.
Key variants
Pathogenic variants in AHI1 are distributed throughout the gene, with both missense changes affecting critical functional domains and truncating variants that eliminate essential protein regions. Loss-of-function variants that severely reduce or abolish AHI1 protein production are frequently observed in individuals with Joubert syndrome. The severity of clinical features can vary depending on the specific combination of variants inherited, with some genotypes associated with milder presentations and others with more extensive involvement of multiple organ systems.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.108dup | p.Leu37fs | Pathogenic/Likely pathogenic | ★★☆☆ | Joubert syndrome 3 |
c.1152-1G>A | - | Pathogenic/Likely pathogenic | ★★☆☆ | Joubert syndrome |
c.1550G>A | p.Trp517Ter | Pathogenic | ★★☆☆ | Joubert syndrome 3 |
c.1760G>A | p.Trp587Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Joubert syndrome 3 |
c.1779+1G>T | - | Pathogenic/Likely pathogenic | ★★☆☆ | Joubert syndrome |
c.195_202del | p.Asp65fs | Pathogenic/Likely pathogenic | ★★☆☆ | Joubert syndrome 3 |
c.2057_2060del | p.Asn686fs | Pathogenic | ★★☆☆ | Joubert syndrome |
c.2076_2077del | p.Arg692fs | Pathogenic/Likely pathogenic | ★★☆☆ | Joubert syndrome 3 |
c.3088C>T | p.Gln1030Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Joubert syndrome |
c.3431C>G | p.Ser1144Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Joubert syndrome |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Biallelic pathogenic variants in AHI1 cause Joubert syndrome (AHI1), a rare ciliopathy first described in 1969. This condition is characterised by a distinctive brain malformation called the molar tooth sign, visible on brain imaging, which reflects abnormal development of the cerebellar vermis and brainstem. Affected individuals typically present with low muscle tone in infancy, delayed developmental milestones, and abnormal breathing patterns during the newborn period.
Beyond the neurological features, Joubert syndrome associated with AHI1 variants may affect the kidneys, liver, eyes, and skeletal system, though the range and severity of involvement differs among individuals. Some people develop progressive kidney disease or retinal degeneration, whilst others have primarily neurological symptoms. The condition requires multidisciplinary medical management tailored to each individual's specific manifestations.
Inheritance pattern
Conditions caused by pathogenic AHI1 variants typically follow autosomal recessive inheritance.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
UK clinical status
AHI1 is included on multiple NHS Genomic Medicine Service gene panels with green classification status, reflecting robust evidence for its role in human disease. The gene appears on the DDG2P panel, Fetal anomalies panel (R21), Intellectual disability panel (R29), and several ciliopathy-specific panels including Neurological ciliopathies, Ophthalmological ciliopathies, Rare multisystem ciliopathy disorders, and Renal ciliopathies. It is also listed on the Retinal disorders panel (R32). This comprehensive panel representation supports testing of AHI1 in NHS laboratories when clinical features suggest a ciliopathy diagnosis.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the inheritance pattern for AHI1-related conditions?
AHI1-related Joubert syndrome follows an autosomal recessive inheritance pattern. This means an affected individual has inherited a pathogenic variant from each parent. Parents who carry one pathogenic variant are typically unaffected and have a 25% chance with each pregnancy of having an affected child.
Are all cases of Joubert syndrome caused by AHI1 variants?
No, Joubert syndrome is genetically heterogeneous, meaning pathogenic variants in many different genes can cause the condition. AHI1 accounts for a subset of cases, whilst other ciliary genes are responsible for the majority. Genetic testing often involves panel sequencing to identify the specific causative gene.
Can carriers of one AHI1 variant develop symptoms?
Carriers with one pathogenic AHI1 variant are generally asymptomatic and do not develop Joubert syndrome. Symptoms typically only occur when both gene copies carry pathogenic variants, resulting in severely reduced or absent functional protein.